Loading…

Diazanorbornene: A Valuable Synthon towards Carbocycles and Heterocycles

Desymmetrization of meso compounds is well recognized as a powerful method for delivering biologically relevant molecular skeletons in a few synthetic steps. Heterobicyclic olefins are a class of meso compounds which exhibit exceptional reactivity due to their high ring strain originating from the u...

Full description

Saved in:
Bibliographic Details
Published in:European journal of organic chemistry 2020-11, Vol.2020 (42), p.6588-6613
Main Authors: Preethalayam, Preethanuj, Jijy, E., Prakash, Praveen, Chand Sarngadharan, Sarath, Vijayan, Ajesh, Radhakrishnan, K. V., John, Jubi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Desymmetrization of meso compounds is well recognized as a powerful method for delivering biologically relevant molecular skeletons in a few synthetic steps. Heterobicyclic olefins are a class of meso compounds which exhibit exceptional reactivity due to their high ring strain originating from the unfavorable bond angles and eclipsing interactions. Extensive research was carried out towards the synthetic transformations of oxa‐, aza‐, and diazanorbornenes/norbornadienes for the synthesis of a wide variety of carbocycles and heterocycles in a single step, most importantly in a stereo‐ and chemo‐selective manner. This review summarizes the relevant aspects of diazanorbornene reactivity which will inspire the synthetic community for exploiting these highly strained bicyclic systems for the creation of extensive libraries of novel structurally and biologically interesting molecules. The review is divided into several sections based on the type of reactions that diazanorbornenes are subjected to. The present review summarizes the recent progress on desymmetrization of diazanorbornenes towards substituted/fused cyclopentanoids through catalyzed or uncatalyzed pathways.
ISSN:1434-193X
1099-0690
DOI:10.1002/ejoc.202001131